Management of candida peritonitis in a CAPD patient by flucytosine therapy: importance of drug level monitoring in body fluids.
A case of Candida albicans peritonitis in a CAPD patient successfully treated with Flucytosine is reported. Flucytosine blood levels were monitored during intraperitoneal, intravenous and oral administration.
D001826:Body Fluids / Q000032:analysis*; D002177:Candidiasis / Q000188:drug therapy* / Q000209:etiology; D003596:Cytosine / Q000031:analogs & derivatives*; D005437:Flucytosine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology
D003596:Cytosine; D005437:Flucytosine